Carisma Therapeutics, co-founded by Saar Gill, MD, PhD, Associate Professor of Medicine at Penn Medicine, is merging with OrthoCellix to create a publicly traded company focused on developing a first-in-class regenerative therapy for knee cartilage repair. Read more here.